• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺乏端粒酶激活的情况下正常人类细胞的转化。

Transformation of normal human cells in the absence of telomerase activation.

作者信息

Seger Yvette R, García-Cao Marta, Piccinin Sara, Cunsolo Crocifissa Lo, Doglioni Claudio, Blasco María A, Hannon Gregory J, Maestro Roberta

机构信息

Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.

出版信息

Cancer Cell. 2002 Nov;2(5):401-13. doi: 10.1016/s1535-6108(02)00183-6.

DOI:10.1016/s1535-6108(02)00183-6
PMID:12450795
Abstract

Our knowledge of the transformation process has emerged largely from studies of primary rodent cells and animal models. However, numerous attempts to transform human cells using oncogene combinations that are effective in rodents have proven unsuccessful. These findings strongly argue for the study of homologous experimental systems. Here we report that the combined expression of adenovirus E1A, Ha-RasV12, and MDM2 is sufficient to convert a normal human cell into a cancer cell. Notably, transformation did not require telomerase activation. Therefore, we provide evidence that activation of telomere maintenance strategies is not an obligate characteristic of tumorigenic human cells.

摘要

我们对转化过程的认识很大程度上源于对原代啮齿动物细胞和动物模型的研究。然而,使用在啮齿动物中有效的癌基因组合来转化人类细胞的众多尝试均以失败告终。这些发现有力地支持了对同源实验系统的研究。在此,我们报告腺病毒E1A、Ha-RasV12和MDM2的联合表达足以将正常人类细胞转化为癌细胞。值得注意的是,转化并不需要端粒酶激活。因此,我们提供了证据表明端粒维持策略的激活并非致瘤性人类细胞的必然特征。

相似文献

1
Transformation of normal human cells in the absence of telomerase activation.在缺乏端粒酶激活的情况下正常人类细胞的转化。
Cancer Cell. 2002 Nov;2(5):401-13. doi: 10.1016/s1535-6108(02)00183-6.
2
Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.癌基因表达对人内皮细胞、成纤维细胞和前列腺上皮细胞中端粒酶激活及端粒长度的影响。
Int J Oncol. 1998 Nov;13(5):1043-8. doi: 10.3892/ijo.13.5.1043.
3
Telomerase maintains telomere structure in normal human cells.端粒酶维持正常人类细胞中的端粒结构。
Cell. 2003 Jul 25;114(2):241-53. doi: 10.1016/s0092-8674(03)00550-6.
4
Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.人成纤维细胞永生化过程中的端粒动力学、端对端融合及端粒酶激活
Oncogene. 1999 Jul 22;18(29):4211-23. doi: 10.1038/sj.onc.1202797.
5
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.缺乏端粒酶RNA的小鼠细胞中的端粒缩短与肿瘤形成
Cell. 1997 Oct 3;91(1):25-34. doi: 10.1016/s0092-8674(01)80006-4.
6
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.通过端粒酶逆转录酶、SV40 T抗原和致癌性N-ras的共表达对人内皮细胞恶性转化的多个阶段进行建模。
Oncogene. 2002 Jun 20;21(27):4200-11. doi: 10.1038/sj.onc.1205425.
7
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.端粒酶通过一种不依赖端粒长度的机制促进肿瘤发生。
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12606-11. doi: 10.1073/pnas.182407599. Epub 2002 Aug 22.
8
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.体外端粒酶活性、端粒维持和细胞永生化之间的解离。
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8. doi: 10.1073/pnas.95.25.14723.
9
Telomere maintenance in tumour cells.
Cancer Surv. 1996;28:197-216.
10
Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation.永生化人骨髓间充质干细胞在转化过程中的转录动力学
PLoS One. 2015 May 15;10(5):e0126562. doi: 10.1371/journal.pone.0126562. eCollection 2015.

引用本文的文献

1
O-GlcNAcylation of FOXK1 co-opts BAP1 to orchestrate the E2F pathway and promotes oncogenesis.FOXK1的O-连接N-乙酰葡糖胺化作用借助BAP1来协调E2F信号通路并促进肿瘤发生。
Nat Commun. 2025 Jul 1;16(1):5959. doi: 10.1038/s41467-025-61022-7.
2
The complex interplay between aging and cancer.衰老与癌症之间复杂的相互作用。
Nat Aging. 2025 Mar;5(3):350-365. doi: 10.1038/s43587-025-00827-z. Epub 2025 Mar 4.
3
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).间皮瘤中的端粒与端粒酶:病理生理学、生物标志物及新兴治疗策略(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
4
Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle.肥胖-衰老-乳腺癌:一个常见不幸循环的临床表现。
Adv Exp Med Biol. 2024;1460:821-850. doi: 10.1007/978-3-031-63657-8_27.
5
O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis.FOXK1的O-连接N-乙酰葡糖胺化调控E2F信号通路并促进肿瘤发生。
bioRxiv. 2024 Mar 1:2024.03.01.582838. doi: 10.1101/2024.03.01.582838.
6
Starvation-induced proteasome assemblies in the nucleus link amino acid supply to apoptosis.饥饿诱导的核蛋白酶体组装将氨基酸供应与细胞凋亡联系起来。
Nat Commun. 2021 Nov 30;12(1):6984. doi: 10.1038/s41467-021-27306-4.
7
YY1 Silencing Induces 5-Fluorouracil-Resistance and Downregulation in Colorectal Cancer Cells: Diagnostic and Prognostic Relevance.YY1 沉默诱导结直肠癌细胞对氟尿嘧啶耐药及下调:诊断和预后相关性。
Int J Mol Sci. 2021 Aug 6;22(16):8481. doi: 10.3390/ijms22168481.
8
Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.转录因子 Yin Yang 1 及其选择性识别的靶标 Survivin 在高级别 B 细胞非霍奇金淋巴瘤中的作用:潜在的诊断和治疗靶点。
Int J Mol Sci. 2020 Sep 3;21(17):6446. doi: 10.3390/ijms21176446.
9
A Driver Never Works Alone-Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer.驱动因素从不单独起作用——人类癌症中突变型p53、MYC、RAS及其他常见致癌驱动因素的相互作用网络
Cancers (Basel). 2020 Jun 11;12(6):1532. doi: 10.3390/cancers12061532.
10
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.NR4A3 融合蛋白触发轴突导向开关,标志着 EWSR1 和 TAF15 易位的骨外黏液样软骨肉瘤之间的差异。
J Pathol. 2019 Sep;249(1):90-101. doi: 10.1002/path.5284. Epub 2019 May 14.